APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza A Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Influenza A Vaccine Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchInfluenza A Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza A Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Influenza A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza A Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza A Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Influenza A Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Influenza A Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Influenza A Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Influenza A Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Influenza A Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Influenza A Vaccine include Changsheng Bio-Technology, Abbott, Sanofi, Novartis, Merck, Sinovac Biotech, Hualan Biological Engineering, GSK and Beijing Tiantan Bio-Products, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Influenza A Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Influenza A Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Influenza A Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza A Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Influenza A Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Influenza A Vaccine sales, projected growth trends, production technology, application and end-user industry.

Influenza A Vaccine Segment by Company

Changsheng Bio-Technology

Abbott

Sanofi

Novartis

Merck

Sinovac Biotech

Hualan Biological Engineering

GSK

Beijing Tiantan Bio-Products

Mitsubishi Tanabe Pharma

Medimmune

Influenza A Vaccine Segment by Type

Intramuscular Vaccine

Nasal Spray Vaccine

Influenza A Vaccine Segment by Application

3-18 Years Old

Above 18 Years Old

Influenza A Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza A Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Influenza A Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Influenza A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza A Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Influenza A Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Intramuscular Vaccine Major Manufacturers Table 3. Nasal Spray Vaccine Major Manufacturers Table 4. Global Influenza A Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. 3-18 Years Old Major Manufacturers Table 6. Above 18 Years Old Major Manufacturers Table 7. Influenza A Vaccine Industry Trends Table 8. Influenza A Vaccine Industry Drivers Table 9. Influenza A Vaccine Industry Opportunities and Challenges Table 10. Influenza A Vaccine Industry Restraints Table 11. Global Influenza A Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Influenza A Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Influenza A Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Influenza A Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Influenza A Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Influenza A Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Influenza A Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global Influenza A Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global Influenza A Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Influenza A Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Influenza A Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Influenza A Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Influenza A Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Influenza A Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Influenza A Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Influenza A Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Influenza A Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Influenza A Vaccine Manufacturers, Product Type & Application Table 29. Global Influenza A Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Influenza A Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Influenza A Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Influenza A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Influenza A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Influenza A Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Influenza A Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Influenza A Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global Influenza A Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Influenza A Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Influenza A Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global Influenza A Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global Influenza A Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Influenza A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Influenza A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Influenza A Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Influenza A Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Influenza A Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global Influenza A Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Influenza A Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Influenza A Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global Influenza A Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. Changsheng Bio-Technology Company Information Table 57. Changsheng Bio-Technology Business Overview Table 58. Changsheng Bio-Technology Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Changsheng Bio-Technology Influenza A Vaccine Product Portfolio Table 60. Changsheng Bio-Technology Recent Development Table 61. Abbott Company Information Table 62. Abbott Business Overview Table 63. Abbott Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Abbott Influenza A Vaccine Product Portfolio Table 65. Abbott Recent Development Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Sanofi Influenza A Vaccine Product Portfolio Table 70. Sanofi Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Influenza A Vaccine Product Portfolio Table 75. Novartis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck Influenza A Vaccine Product Portfolio Table 80. Merck Recent Development Table 81. Sinovac Biotech Company Information Table 82. Sinovac Biotech Business Overview Table 83. Sinovac Biotech Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sinovac Biotech Influenza A Vaccine Product Portfolio Table 85. Sinovac Biotech Recent Development Table 86. Hualan Biological Engineering Company Information Table 87. Hualan Biological Engineering Business Overview Table 88. Hualan Biological Engineering Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Hualan Biological Engineering Influenza A Vaccine Product Portfolio Table 90. Hualan Biological Engineering Recent Development Table 91. GSK Company Information Table 92. GSK Business Overview Table 93. GSK Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. GSK Influenza A Vaccine Product Portfolio Table 95. GSK Recent Development Table 96. Beijing Tiantan Bio-Products Company Information Table 97. Beijing Tiantan Bio-Products Business Overview Table 98. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolio Table 100. Beijing Tiantan Bio-Products Recent Development Table 101. Mitsubishi Tanabe Pharma Company Information Table 102. Mitsubishi Tanabe Pharma Business Overview Table 103. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolio Table 105. Mitsubishi Tanabe Pharma Recent Development Table 106. Medimmune Company Information Table 107. Medimmune Business Overview Table 108. Medimmune Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Medimmune Influenza A Vaccine Product Portfolio Table 110. Medimmune Recent Development Table 111. North America Influenza A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Influenza A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 114. North America Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 115. North America Influenza A Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 116. North America Influenza A Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 117. North America Influenza A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Influenza A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 120. North America Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 121. North America Influenza A Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 122. North America Influenza A Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 123. North America Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Influenza A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Influenza A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 127. North America Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 128. North America Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 129. North America Influenza A Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 130. North America Influenza A Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 131. United States Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 132. Canada Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 133. Mexico Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 134. Europe Influenza A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Influenza A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 137. Europe Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 138. Europe Influenza A Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 139. Europe Influenza A Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 140. Europe Influenza A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Influenza A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 143. Europe Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 144. Europe Influenza A Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 145. Europe Influenza A Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 146. Europe Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Influenza A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Influenza A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 150. Europe Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 151. Europe Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 152. Europe Influenza A Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 153. Europe Influenza A Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 154. Germany Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 155. France Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 156. U.K. Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 157. Italy Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 158. Russia Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 159. Spain Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 160. Netherlands Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 161. Switzerland Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 162. Sweden Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 163. Poland Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 164. China Influenza A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 165. China Influenza A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 166. China Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 167. China Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 168. China Influenza A Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 169. China Influenza A Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 170. China Influenza A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 171. China Influenza A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 172. China Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 173. China Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 174. China Influenza A Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 175. China Influenza A Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 176. Asia Influenza A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Influenza A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 179. Asia Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 180. Asia Influenza A Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 181. Asia Influenza A Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 182. Asia Influenza A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Influenza A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 185. Asia Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 186. Asia Influenza A Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 187. Asia Influenza A Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 188. Asia Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Influenza A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Influenza A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 192. Asia Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 193. Asia Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 194. Asia Influenza A Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 195. Asia Influenza A Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 196. Japan Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 197. South Korea Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 198. India Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 199. Australia Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Taiwan Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Influenza A Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Influenza A Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 205. SAMEA Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 206. SAMEA Influenza A Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 207. SAMEA Influenza A Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 208. SAMEA Influenza A Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Influenza A Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 211. SAMEA Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 212. SAMEA Influenza A Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 213. SAMEA Influenza A Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 214. SAMEA Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Influenza A Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Influenza A Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 218. SAMEA Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 219. SAMEA Influenza A Vaccine Sales by Country (2027-2032) & (k units) Table 220. SAMEA Influenza A Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 221. SAMEA Influenza A Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 222. Brazil Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Argentina Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 224. Chile Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 225. Colombia Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 226. Peru Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 228. Israel Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 229. UAE Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Turkey Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Iran Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Egypt Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Influenza A Vaccine Distributors List Table 236. Influenza A Vaccine Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Influenza A Vaccine Image Figure 2. Global Influenza A Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza A Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Intramuscular Vaccine Image Figure 5. Nasal Spray Vaccine Image Figure 6. Global Influenza A Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Influenza A Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. 3-18 Years Old Image Figure 9. Above 18 Years Old Image Figure 10. Global Influenza A Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Influenza A Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Influenza A Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Influenza A Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Influenza A Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Influenza A Vaccine Sales (2021-2032) & (k units) Figure 16. Global Influenza A Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Influenza A Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Influenza A Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe Influenza A Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China Influenza A Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Influenza A Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Influenza A Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global Influenza A Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Influenza A Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Influenza A Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Influenza A Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Influenza A Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Influenza A Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Influenza A Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Influenza A Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Influenza A Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Influenza A Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Influenza A Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Influenza A Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Influenza A Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Influenza A Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Influenza A Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Influenza A Vaccine Sales Share by Type (2021-2032) Figure 40. North America Influenza A Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Influenza A Vaccine Sales Share by Application (2021-2032) Figure 42. North America Influenza A Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Influenza A Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Influenza A Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Influenza A Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Influenza A Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Influenza A Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Influenza A Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Influenza A Vaccine Sales Share by Country (2021-2032) Figure 50. China Influenza A Vaccine Revenue Share by Type (2021-2032) Figure 51. China Influenza A Vaccine Sales Share by Type (2021-2032) Figure 52. China Influenza A Vaccine Revenue Share by Application (2021-2032) Figure 53. China Influenza A Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Influenza A Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Influenza A Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Influenza A Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Influenza A Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Influenza A Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Influenza A Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Influenza A Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Influenza A Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Influenza A Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Influenza A Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Influenza A Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Influenza A Vaccine Sales Share by Country (2021-2032) Figure 66. Influenza A Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Influenza A Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Vaccine
  • Nasal Spray Vaccine
Applications
  • 3-18 Years Old
  • Above 18 Years Old
Companies covered
  • Changsheng Bio-Technology
  • Abbott
  • Sanofi
  • Novartis
  • Merck
  • Sinovac Biotech
  • Hualan Biological Engineering
  • GSK
  • Beijing Tiantan Bio-Products
  • Mitsubishi Tanabe Pharma
  • Medimmune

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Influenza A Vaccine Market by Type
  3. 1.2.1 Global Influenza A Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Intramuscular Vaccine
  5. 1.2.3 Nasal Spray Vaccine
  6. 1.3 Influenza A Vaccine Market by Application
  7. 1.3.1 Global Influenza A Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 3-18 Years Old
  9. 1.3.3 Above 18 Years Old
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Influenza A Vaccine Market Dynamics
  1. 2.1 Influenza A Vaccine Industry Trends
  2. 2.2 Influenza A Vaccine Industry Drivers
  3. 2.3 Influenza A Vaccine Industry Opportunities and Challenges
  4. 2.4 Influenza A Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Influenza A Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Influenza A Vaccine Revenue by Region
  3. 3.2.1 Global Influenza A Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Influenza A Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Influenza A Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Influenza A Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Influenza A Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Influenza A Vaccine Sales by Region
  9. 3.4.1 Global Influenza A Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Influenza A Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Influenza A Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Influenza A Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Influenza A Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Influenza A Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Influenza A Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Influenza A Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Influenza A Vaccine Sales by Manufacturers
  6. 4.2.1 Global Influenza A Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Influenza A Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Influenza A Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Influenza A Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Influenza A Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Influenza A Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Influenza A Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Influenza A Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Influenza A Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Influenza A Vaccine Tier 1, Tier 2, and Tier 3
5 Influenza A Vaccine Market by Type
  1. 5.1 Global Influenza A Vaccine Revenue by Type
  2. 5.1.1 Global Influenza A Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Influenza A Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Influenza A Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Influenza A Vaccine Sales by Type
  6. 5.2.1 Global Influenza A Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Influenza A Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Influenza A Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Influenza A Vaccine Price by Type
6 Influenza A Vaccine Market by Application
  1. 6.1 Global Influenza A Vaccine Revenue by Application
  2. 6.1.1 Global Influenza A Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Influenza A Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Influenza A Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Influenza A Vaccine Sales by Application
  6. 6.2.1 Global Influenza A Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Influenza A Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Influenza A Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Influenza A Vaccine Price by Application
7 Company Profiles
  1. 7.1 Changsheng Bio-Technology
  2. 7.1.1 Changsheng Bio-Technology Company Information
  3. 7.1.2 Changsheng Bio-Technology Business Overview
  4. 7.1.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Changsheng Bio-Technology Influenza A Vaccine Product Portfolio
  6. 7.1.5 Changsheng Bio-Technology Recent Developments
  7. 7.2 Abbott
  8. 7.2.1 Abbott Company Information
  9. 7.2.2 Abbott Business Overview
  10. 7.2.3 Abbott Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Influenza A Vaccine Product Portfolio
  12. 7.2.5 Abbott Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Influenza A Vaccine Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Influenza A Vaccine Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Influenza A Vaccine Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Sinovac Biotech
  32. 7.6.1 Sinovac Biotech Company Information
  33. 7.6.2 Sinovac Biotech Business Overview
  34. 7.6.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sinovac Biotech Influenza A Vaccine Product Portfolio
  36. 7.6.5 Sinovac Biotech Recent Developments
  37. 7.7 Hualan Biological Engineering
  38. 7.7.1 Hualan Biological Engineering Company Information
  39. 7.7.2 Hualan Biological Engineering Business Overview
  40. 7.7.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hualan Biological Engineering Influenza A Vaccine Product Portfolio
  42. 7.7.5 Hualan Biological Engineering Recent Developments
  43. 7.8 GSK
  44. 7.8.1 GSK Company Information
  45. 7.8.2 GSK Business Overview
  46. 7.8.3 GSK Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GSK Influenza A Vaccine Product Portfolio
  48. 7.8.5 GSK Recent Developments
  49. 7.9 Beijing Tiantan Bio-Products
  50. 7.9.1 Beijing Tiantan Bio-Products Company Information
  51. 7.9.2 Beijing Tiantan Bio-Products Business Overview
  52. 7.9.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolio
  54. 7.9.5 Beijing Tiantan Bio-Products Recent Developments
  55. 7.10 Mitsubishi Tanabe Pharma
  56. 7.10.1 Mitsubishi Tanabe Pharma Company Information
  57. 7.10.2 Mitsubishi Tanabe Pharma Business Overview
  58. 7.10.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolio
  60. 7.10.5 Mitsubishi Tanabe Pharma Recent Developments
  61. 7.11 Medimmune
  62. 7.11.1 Medimmune Company Information
  63. 7.11.2 Medimmune Business Overview
  64. 7.11.3 Medimmune Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Medimmune Influenza A Vaccine Product Portfolio
  66. 7.11.5 Medimmune Recent Developments
8 North America
  1. 8.1 North America Influenza A Vaccine Market Size by Type
  2. 8.1.1 North America Influenza A Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Influenza A Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Influenza A Vaccine Price by Type (2021-2032)
  5. 8.2 North America Influenza A Vaccine Market Size by Application
  6. 8.2.1 North America Influenza A Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Influenza A Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Influenza A Vaccine Price by Application (2021-2032)
  9. 8.3 North America Influenza A Vaccine Market Size by Country
  10. 8.3.1 North America Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Influenza A Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Influenza A Vaccine Market Size by Type
  2. 9.1.1 Europe Influenza A Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Influenza A Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Influenza A Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Influenza A Vaccine Market Size by Application
  6. 9.2.1 Europe Influenza A Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Influenza A Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Influenza A Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Influenza A Vaccine Market Size by Country
  10. 9.3.1 Europe Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Influenza A Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Influenza A Vaccine Market Size by Type
  2. 10.1.1 China Influenza A Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Influenza A Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Influenza A Vaccine Price by Type (2021-2032)
  5. 10.2 China Influenza A Vaccine Market Size by Application
  6. 10.2.1 China Influenza A Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Influenza A Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Influenza A Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Influenza A Vaccine Market Size by Type
  2. 11.1.1 Asia Influenza A Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Influenza A Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Influenza A Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Influenza A Vaccine Market Size by Application
  6. 11.2.1 Asia Influenza A Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Influenza A Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Influenza A Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Influenza A Vaccine Market Size by Country
  10. 11.3.1 Asia Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Influenza A Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Influenza A Vaccine Market Size by Type
  2. 12.1.1 SAMEA Influenza A Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Influenza A Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Influenza A Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Influenza A Vaccine Market Size by Application
  6. 12.2.1 SAMEA Influenza A Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Influenza A Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Influenza A Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Influenza A Vaccine Market Size by Country
  10. 12.3.1 SAMEA Influenza A Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Influenza A Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Influenza A Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Influenza A Vaccine Value Chain Analysis
  2. 13.1.1 Influenza A Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Influenza A Vaccine Production Mode & Process
  6. 13.2 Influenza A Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Influenza A Vaccine Distributors
  9. 13.2.3 Influenza A Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst